Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...

Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support ...

In a note to investors, UBS analyst Trung Huynh says this acquisition is a step in the right direction for Merck. Ohtuvayre can be used with any “background” medication for COPD, which makes ...

Key Points Merck is seeking ways to prepare for a significant upcoming patent cliff.The company has just announced another acquisition that will help it achieve that goal.With its newer products, ...

U.S.-listed shares of Verona Pharma ( VRNA) soared to an all-time high Wednesday after Merck ( MRK) agreed to pay about $10 ...

(Reuters) -U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung diseases, the Financial Times reported on Wednesday. Merck ...

As Merck & Co. rolls out a widespread cost-cutting initiative, the pharma is dropping an autoimmune asset acquired a few years ago in a nearly $2 billion biotech takeover.

Merck to Buy Verona Pharma in $10 Billion Deal Deal is a 23% premium to Tuesday’s closing price for the London-based company By Colin Kellaher Share ...